170 related articles for article (PubMed ID: 8880817)
1. Cisatracurium during halothane and balanced anaesthesia in children.
Meretoja OA; Taivainen T; Wirtavuori K
Paediatr Anaesth; 1996; 6(5):373-8. PubMed ID: 8880817
[TBL] [Abstract][Full Text] [Related]
2. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia.
Meretoja OA; Taivainen T; Wirtavuori K
Br J Anaesth; 1995 Jan; 74(1):6-11. PubMed ID: 7880708
[TBL] [Abstract][Full Text] [Related]
4. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.
Meakin GH; Meretoja OA; Perkins RJ; Waite I; Taivainen T; Wirtavuori K; Murphy AK; Raiha L
Paediatr Anaesth; 2007 Feb; 17(2):113-20. PubMed ID: 17238881
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of cisatracurium 0.15 mg.kg(-1) during nitrous oxide-opioid anaesthesia in infants and children.
Taivainen T; Meakin GH; Meretoja OA; Wirtavuori K; Perkins RJ; Murphy AK; Fisher GR; Waiter MR
Anaesthesia; 2000 Nov; 55(11):1047-51. PubMed ID: 11069329
[TBL] [Abstract][Full Text] [Related]
6. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia.
Lepage JY; Malinovsky JM; Malinge M; Lechevalier T; Dupuch C; Cozian A; Pinaud M; Souron R
Anesth Analg; 1996 Oct; 83(4):823-9. PubMed ID: 8831329
[TBL] [Abstract][Full Text] [Related]
8. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia.
Kenaan CA; Estacio RL; Bikhazi GB
J Clin Anesth; 2000 May; 12(3):173-6. PubMed ID: 10869913
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
12. [Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].
Soukup J; Doenicke A; Hoernecke R; qass J
Anaesthesist; 1997 Jun; 46(6):486-91. PubMed ID: 9297379
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
15. [The clinical pharmacology of cisatracurium].
Mellinghoff H; Diefenbach C
Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
[TBL] [Abstract][Full Text] [Related]
16. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ
Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945
[TBL] [Abstract][Full Text] [Related]
17. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.
Pittet JF; Tassonyi E; Morel DR; Gemperle G; Richter M; Rouge JC
Anesthesiology; 1989 Aug; 71(2):210-3. PubMed ID: 2547325
[TBL] [Abstract][Full Text] [Related]
18. Duration and recovery profile of cisatracurium after succinylcholine during propofol or isoflurane anesthesia.
Soppitt AJ; Glass PS; el-Moalem H; Ginsberg B; Weatherwax K; Gan TJ
J Clin Anesth; 1999 Dec; 11(8):652-6. PubMed ID: 10680107
[TBL] [Abstract][Full Text] [Related]
19. Influence of the priming technique on pharmacodynamics and intubating conditions of cisatracurium.
Deepika K; Kenaan CA; Bikhazi GB; Martineau DB
J Clin Anesth; 1999 Nov; 11(7):572-5. PubMed ID: 10624642
[TBL] [Abstract][Full Text] [Related]
20. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
Debaene B; Meistelman C; d'Hollander A
Anesthesiology; 1989 Dec; 71(6):840-4. PubMed ID: 2574016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
